Annual EBIT
-$41.47 M
+$52.08 M+55.67%
December 31, 2023
Summary
- As of February 18, 2025, ELEV annual earnings before interest & taxes is -$41.47 million, with the most recent change of +$52.08 million (+55.67%) on December 31, 2023.
- During the last 3 years, ELEV annual EBIT has fallen by -$24.20 million (-140.07%).
- ELEV annual EBIT is now -140.07% below its all-time high of -$17.28 million, reached on December 31, 2020.
Performance
ELEV EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$13.23 M
-$2.27 M-20.67%
September 30, 2024
Summary
- As of February 18, 2025, ELEV quarterly earnings before interest & taxes is -$13.23 million, with the most recent change of -$2.27 million (-20.67%) on September 30, 2024.
- Over the past year, ELEV quarterly EBIT has stayed the same.
- ELEV quarterly EBIT is now -575.29% below its all-time high of -$1.96 million, reached on March 31, 2020.
Performance
ELEV Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$43.14 M
-$2.31 M-5.65%
September 30, 2024
Summary
- As of February 18, 2025, ELEV TTM earnings before interest & taxes is -$43.14 million, with the most recent change of -$2.31 million (-5.65%) on September 30, 2024.
- Over the past year, ELEV TTM EBIT has stayed the same.
- ELEV TTM EBIT is now -2102.30% below its all-time high of -$1.96 million, reached on March 31, 2020.
Performance
ELEV TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ELEV EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.7% | 0.0% | 0.0% |
| 3 y3 years | -140.1% | 0.0% | 0.0% |
| 5 y5 years | - | 0.0% | 0.0% |
ELEV EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.4% | +55.7% | -45.7% | +65.7% | -34.6% | +53.9% |
| 5 y | 5-year | -140.1% | +55.7% | -575.3% | +65.7% | -2102.3% | +53.9% |
| alltime | all time | -140.1% | +55.7% | -575.3% | +65.7% | -2102.3% | +53.9% |
Elevation Oncology EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.23 M(+20.7%) | -$43.14 M(+5.7%) |
| Jun 2024 | - | -$10.96 M(+11.1%) | -$40.83 M(+2.8%) |
| Mar 2024 | - | -$9.87 M(+8.7%) | -$39.70 M(-4.3%) |
| Dec 2023 | -$41.47 M(-55.7%) | -$9.08 M(-16.8%) | -$41.47 M(-16.9%) |
| Sep 2023 | - | -$10.92 M(+11.0%) | -$49.94 M(-35.6%) |
| Jun 2023 | - | -$9.83 M(-15.5%) | -$77.55 M(-11.7%) |
| Mar 2023 | - | -$11.64 M(-33.7%) | -$87.83 M(-6.1%) |
| Dec 2022 | -$93.56 M | -$17.54 M(-54.5%) | -$93.56 M(+9.2%) |
| Sep 2022 | - | -$38.53 M(+91.6%) | -$85.64 M(+44.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$20.11 M(+15.8%) | -$59.38 M(+34.0%) |
| Mar 2022 | - | -$17.37 M(+80.5%) | -$44.33 M(+38.3%) |
| Dec 2021 | -$32.05 M(+85.5%) | -$9.62 M(-21.6%) | -$32.05 M(+2.4%) |
| Sep 2021 | - | -$12.28 M(+142.7%) | -$31.31 M(+42.0%) |
| Jun 2021 | - | -$5.06 M(-0.5%) | -$22.04 M(+8.0%) |
| Mar 2021 | - | -$5.09 M(-42.8%) | -$20.40 M(+18.1%) |
| Dec 2020 | -$17.28 M | -$8.89 M(+195.1%) | -$17.28 M(+105.9%) |
| Sep 2020 | - | -$3.01 M(-11.9%) | -$8.39 M(+56.0%) |
| Jun 2020 | - | -$3.42 M(+74.5%) | -$5.38 M(+174.5%) |
| Mar 2020 | - | -$1.96 M | -$1.96 M |
FAQ
- What is Elevation Oncology annual earnings before interest & taxes?
- What is the all time high annual EBIT for Elevation Oncology?
- What is Elevation Oncology annual EBIT year-on-year change?
- What is Elevation Oncology quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Elevation Oncology?
- What is Elevation Oncology quarterly EBIT year-on-year change?
- What is Elevation Oncology TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Elevation Oncology?
- What is Elevation Oncology TTM EBIT year-on-year change?
What is Elevation Oncology annual earnings before interest & taxes?
The current annual EBIT of ELEV is -$41.47 M
What is the all time high annual EBIT for Elevation Oncology?
Elevation Oncology all-time high annual earnings before interest & taxes is -$17.28 M
What is Elevation Oncology annual EBIT year-on-year change?
Over the past year, ELEV annual earnings before interest & taxes has changed by +$52.08 M (+55.67%)
What is Elevation Oncology quarterly earnings before interest & taxes?
The current quarterly EBIT of ELEV is -$13.23 M
What is the all time high quarterly EBIT for Elevation Oncology?
Elevation Oncology all-time high quarterly earnings before interest & taxes is -$1.96 M
What is Elevation Oncology quarterly EBIT year-on-year change?
Over the past year, ELEV quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Elevation Oncology TTM earnings before interest & taxes?
The current TTM EBIT of ELEV is -$43.14 M
What is the all time high TTM EBIT for Elevation Oncology?
Elevation Oncology all-time high TTM earnings before interest & taxes is -$1.96 M
What is Elevation Oncology TTM EBIT year-on-year change?
Over the past year, ELEV TTM earnings before interest & taxes has changed by $0.00 (0.00%)